• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Clinical validation of optimised RT-LAMP for the diagnosis of SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Aug 10;11(1):16193.
doi: 10.1038/s41598-021-95607-1.
Clinical validation of optimised RT-LAMP for the diagnosis of SARS-CoV-2 infection


Boon Lim[SUP] #[/SUP][SUP] 1 2 [/SUP], Jeremy Ratcliff[SUP] #[/SUP][SUP] 3 [/SUP], Dorota A Nawrot[SUP] #[/SUP][SUP] 4 [/SUP], Yejiong Yu[SUP] 1 2 [/SUP], Harshmeena R Sanghani[SUP] 4 [/SUP], Chia-Chen Hsu[SUP] 1 2 [/SUP], Leon Peto[SUP] 5 [/SUP], Simon Evans[SUP] 5 [/SUP], Susanne H Hodgson[SUP] 5 6 [/SUP], Aikaterini Skeva[SUP] 7 [/SUP], Maria Adam[SUP] 7 [/SUP], Maria Panopoulou[SUP] 7 [/SUP], Christos E Zois[SUP] 7 [/SUP], Katy Poncin[SUP] 8 [/SUP], Sridhar R Vasudevan[SUP] 4 [/SUP], Siqi Dai[SUP] 1 2 [/SUP], Shuai Ren[SUP] 1 2 [/SUP], Hong Chang[SUP] 9 [/SUP], Zhanfeng Cui[SUP] 1 2 9 [/SUP], Peter Simmonds[SUP] 3 [/SUP], Wei E Huang[SUP] 10 11 [/SUP], Monique I Andersson[SUP] 12 13 [/SUP]



Affiliations

Abstract

We have optimised a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay for the detection of SARS-CoV-2 from extracted RNA for clinical application. We improved the stability and reliability of the RT-LAMP assay by the addition of a temperature-dependent switch oligonucleotide to reduce self- or off-target amplification. We then developed freeze-dried master mix for single step RT-LAMP reaction, simplifying the operation for end users and improving long-term storage and transportation. The assay can detect as low as 13 copies of SARS-CoV2 RNA per reaction (25-μL). Cross reactivity with other human coronaviruses was not observed. We have applied the new RT-LAMP assay for testing clinical extracted RNA samples extracted from swabs of 72 patients in the UK and 126 samples from Greece and demonstrated the overall sensitivity of 90.2% (95% CI 83.8-94.7%) and specificity of 92.4% (95% CI 83.2-97.5%). Among 115 positive samples which Ct values were less than 34, the RT-LAMP assay was able to detect 110 of them with 95.6% sensitivity. The specificity was 100% when RNA elution used RNase-free water. The outcome of RT-LAMP can be reported by both colorimetric detection and quantifiable fluorescent reading. Objective measures with a digitized reading data flow would allow for the sharing of results for local or national surveillance.
 
Back
Top Bottom